Archive - January 2021
Roche’s tiragolumab plus Tecentriq combo wins FDA breakthrough therapy designation
New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU
WHO advises both doses of Pfizer/BioNTech’s COVID-19 vaccine within a 21-28 day schedule
Moderna could potentially deliver one billion COVID-19 vaccine doses this year
EU authorises intramuscular administration of Biogen’s Plegridy for MS
Allergy Therapeutics launches biomarker study of peanut allergy vaccine candidate
US priority review for Forxiga in chronic kidney disease
University of Birmingham researchers develop rapid COVID-19 RNA test